|
|
|
Volumn 4, Issue 10, 2006, Pages 732-733
|
|
Causes, predictors of death, and antithrombotic treatment in cerebral venous thrombosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);
ANTICOAGULANT AGENT;
ANTINEOPLASTIC AGENT;
BLOOD CLOTTING FACTOR 5 LEIDEN;
FATTY ACID BINDING PROTEIN;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
ORAL CONTRACEPTIVE AGENT;
PROTEIN C;
PROTHROMBIN;
STEROID;
AGE;
ANTICOAGULANT THERAPY;
ANTIPHOSPHOLIPID SYNDROME;
ARTICLE;
BLOOD CLOT LYSIS;
BRAIN VEIN;
CONSENSUS DEVELOPMENT;
DEATH;
DISEASE ASSOCIATION;
DRUG CONTRAINDICATION;
FEMALE;
GENE MUTATION;
HEADACHE;
HUMAN;
HYPERHOMOCYSTEINEMIA;
INCIDENCE;
LUMBAR PUNCTURE;
MALE;
MORTALITY;
NEUROSURGERY;
OCCLUSIVE CEREBROVASCULAR DISEASE;
PATHOGENESIS;
PRACTICE GUIDELINE;
PREDICTION;
PREVALENCE;
PROGNOSIS;
PROMOTER REGION;
RECURRENCE RISK;
SEIZURE;
SEX DIFFERENCE;
THROMBOPHILIA;
FIBRINOLYTIC AGENTS;
GENETIC PREDISPOSITION TO DISEASE;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
INTRACRANIAL THROMBOSIS;
MUTATION;
RECURRENCE;
VENOUS THROMBOSIS;
|
|
EID: 33751259070
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (14)
|
|
References (6)
|
